Arrail Group (HKG:6639) Full Year 2025 Results
Key Financial Results
- Revenue: CN¥1.69b (down 3.3% from FY 2024).
- Net income: CN¥22.0m (up 28% from FY 2024).
- Profit margin: 1.3% (up from 1.0% in FY 2024).
- EPS: CN¥0.049 (up from CN¥0.037 in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Arrail Group Earnings Insights
The primary driver behind last 12 months revenue was the Rytime Dental segment contributing a total revenue of CN¥953.0m (56% of total revenue). Notably, cost of sales worth CN¥1.35b amounted to 80% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥173.9m (54% of total expenses). Explore how 6639's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Healthcare industry in Hong Kong.
Performance of the Hong Kong Healthcare industry.
The company's shares are up 19% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Arrail Group that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Arrail Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.